An 1H-MRS framework predicts the onset of Alzheimer's disease symptoms in PSEN1 mutation carriers

Alzheimer's and Dementia

Volumn 10, Issue 5, 2014, Pages 552-561

  Londono, Ana C ^a   Castellanos, Francisco X ^b   Arbelaez, Andres ^c   Ruiz, Adriana ^d   Aguirre Acevedo, Daniel C ^d   Richardson, Alice M ^e,f   Easteal, Simon ^f   Lidbury, Brett A ^f   Arcos Burgos, Mauricio ^f   Lopera, Francisco ^d  

^a Antioquia   (Colombia)

^b NEW YORK UNIVERSITY CHILD STUDY CENTER   (United States)

^c Division of Otolaryngology   (Colombia)

^d UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^e UNIVERSITY OF CANBERRA   (Australia)

^f Australian National University   (Australia)

Author keywords

Alzheimer's disease; Familial Alzheimer's; Prediction; PSEN1

Indexed keywords

CHOLINE; GLUTAMIC ACID; GLUTAMINE; INOSITOL; N ACETYLASPARTIC ACID; PRESENILIN 1; PSEN1 PROTEIN, HUMAN;

ALZHEIMER DISEASE; ARTICLE; BRAIN LEVEL; BRAIN METABOLISM; CONCEPTUAL FRAMEWORK; CONTROLLED STUDY; DECISION TREE; FEMALE; GENE; GENE MUTATION; GRAY MATTER; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; ONSET AGE; OUTCOME ASSESSMENT; PEDIGREE; PENETRANCE; POSTERIOR CINGULATE; PRECUNEUS; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; PSEN1 GENE; SENSITIVITY AND SPECIFICITY; BIOLOGICAL MODEL; BRAIN; EARLY DIAGNOSIS; GENETICS; METABOLISM; MUTATION; PROCEDURES; RECEIVER OPERATING CHARACTERISTIC; SIGNAL PROCESSING;

ALZHEIMER DISEASE; BRAIN; EARLY DIAGNOSIS; FEMALE; HETEROZYGOTE; HUMANS; MALE; MILD COGNITIVE IMPAIRMENT; MODELS, NEUROLOGICAL; MUTATION; PRESENILIN-1; PROTON MAGNETIC RESONANCE SPECTROSCOPY; ROC CURVE; SENSITIVITY AND SPECIFICITY; SIGNAL PROCESSING, COMPUTER-ASSISTED;

EID: 85027925466     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2013.08.282     Document Type: Article

References (54)

1. A. Burns Alzheimer's disease: on the verges of treatment and prevention Lancet Neurol 8 2009 4 5
2. P.B. Rosenberg, and A.E. Hillis Biomarkers for Alzheimer's disease: ready for the next step Brain 132 2009 2002 2004
3. R.C. Petersen, G.E. Smith, S.C. Waring, R.J. Ivnik, E.G. Tangalos, and E. Kokmen Mild cognitive impairment: clinical characterization and outcome Arch Neurol 56 1999 303 308
4. C. Davatzikos, F. Xu, Y. An, Y. Fan, and S.M. Resnick Longitudinal progression of Alzheimer's-like patterns of atrophy in normal older adults: the SPARE-AD index Brain 132 2009 2026 2035
5. 1H MR spectroscopy in common dementias Neurology 63 2004 1393 1398
6. K. Kantarci, S.D. Weigand, S.A. Przybelski, M.M. Shiung, J.L. Whitwell, and S. Negash et al. Risk of dementia in MCI: combined effect of cerebrovascular disease, volumetric MRI, and 1H MRS Neurology 72 2009 1519 1525
7. F. Jessen, O. Gür, W. Block, G. Ende, L. Frölich, and T. Hammen et al. A multicenter (1)H-MRS study of the medial temporal lobe in AD and MCI Neurology 72 2009 1735 1740
8. S.M. Nestor, R. Rupsingh, M. Borrie, M. Smith, V. Accomazzi, and J.L. Wells et al. Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database Brain 131 2008 2443 2454
9. R.S. Desikan, H.J. Cabral, C.P. Hess, W.P. Dillon, C.M. Glastonbury, and M.W. Weiner et al. Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer's disease Brain 132 2009 2048 2057
10. R.S. Desikan, H.J. Cabral, F. Settecase, C.P. Hess, W.P. Dillon, and C.M. Glastonbury et al. Automated MRI measures predict progression to Alzheimer's disease Neurobiol Aging 31 2010 1364 1374
11. O. Querbes, F. Aubry, J. Pariente, J.A. Lotterie, J.F. Démonet, and V. Duret et al. Early diagnosis of Alzheimer's disease using cortical thickness: impact of cognitive reserve Brain 132 2009 2036 2047
12. J.L. Whitwell, R.C. Petersen, S. Negash, S.D. Weigand, K. Kantarci, and R.J. Ivnik et al. Patterns of atrophy differ among specific subtypes of mild cognitive impairment Arch Neurol 64 2007 1130 1138
13. C.R. Jack Jr., V.J. Lowe, M.L. Senjem, S.D. Weigand, B.J. Kemp, and M.M. Shiung et al. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment Brain 131 2008 665 680
14. M. Ewers, Z. Zhong, K. Burger, A. Wallin, K. Blennow, and S.J. Teipel et al. Increased CSF-BACE 1 activity is associated with ApoE-epsilon 4 genotype in subjects with mild cognitive impairment and Alzheimer's disease Brain 131 2008 1252 1258
15. L. Mosconi, W.H. Tsui, K. Herholz, A. Pupi, A. Drzezga, and G. Lucignani et al. Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias J Nucl Med 49 2008 390 398
16. L. Mosconi, W.H. Tsui, A. Pupi, S. De Santi, A. Drzezga, and S. Minoshima et al. (18)F-FDG PET database of longitudinally confirmed healthy elderly individuals improves detection of mild cognitive impairment and Alzheimer's disease J Nucl Med 48 2007 1129 1134
17. M. Fouquet, B. Desgranges, B. Landeau, E. Duchesnay, F. Mézenge, and V. de la Sayette et al. Longitudinal brain metabolic changes from amnestic mild cognitive impairment to Alzheimer's disease Brain 132 2009 2058 2067
18. W. Block, F. Traber, S. Flacke, F. Jessen, C. Pohl, and H. Schild In-vivo proton MR-spectroscopy of the human brain: assessment of N-acetylaspartate (NAA) reduction as a marker for neurodegeneration Amino Acids 23 2002 317 323
19. K. Kantarci, C.R. Jack Jr., Y.C. Xu, M.L. Senjem, S.D. Weigand, and R.J. Ivnik et al. Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study Neurology 55 2000 210 217
20. K. Kantarci, V. Lowe, S.A. Przybelski, M.L. Senjem, S.D. Weigand, and R.J. Ivnik et al. Magnetic resonance spectroscopy, beta-amyloid load, and cognition in a population-based sample of cognitively normal older adults Neurology 77 2011 951 958
21. F. Jessen, P. Lewczuk, O. Gür, W. Block, G. Ende, and L. Frölich et al. Association of N-acetylaspartate and cerebrospinal fluid Abeta42 in dementia J Alzheimers Dis 27 2011 393 399
22. K. Kantarci, D.S. Knopman, D.W. Dickson, J.E. Parisi, J.L. Whitwell, and S.D. Weigand et al. Alzheimer disease: postmortem neuropathologic correlates of antemortem 1H MR spectroscopy metabolite measurements Radiology 248 2008 210 220
23. M. Catani, A. Cherubini, R. Howard, R. Tarducci, G.P. Pelliccioli, and M. Piccirilli et al. (1)H-MR spectroscopy differentiates mild cognitive impairment from normal brain aging Neuroreport 12 2001 2315 2317
24. W. Huang, G.E. Alexander, L. Chang, H.U. Shetty, J.S. Krasuski, and S.I. Rapoport et al. Brain metabolite concentration and dementia severity in Alzheimer's disease: a (1)H MRS study Neurology 57 2001 626 632
25. A. Metastasio, P. Rinaldi, R. Tarducci, E. Mariani, F.T. Feliziani, and A. Cherubini et al. Conversion of MCI to dementia: role of proton magnetic resonance spectroscopy Neurobiol Aging 27 2006 926 932
26. R. Bartha, M. Smith, R. Rupsingh, J. Rylett, J.L. Wells, and M.J. Borrie High field (1)H MRS of the hippocampus after donepezil treatment in Alzheimer disease Prog Neuropsychopharmacol Biol Psychiatry 32 2008 786 793
27. M. Arcos-Burgos, and M. Muenke Genetics of population isolates Clin Genet 61 2002 233 247
28. F. Lopera, A. Ardilla, A. Martinez, L. Madrigal, J.C. Arango-Viana, and C.A. Lemere et al. Clinical features of early-onset Alzheimer disease in a large kindred with an E280A presenilin-1 mutation JAMA 277 1997 793 799
29. M.L. Bravo, C.Y. Valenzuela, and O.M. Arcos-Burgos Polymorphisms and phyletic relationships of the Paisa community from Antioquia (Colombia) Gene geography: a computerized bulletin on human gene frequencies 10 1996 11 17
30. N. Acosta-Baena, D. Sepulveda-Falla, C.M. Lopera-Gomez, M.C. Jaramillo-Elorza, S. Moreno, and D.C. Aguirre-Acevedo et al. Pre-dementia clinical stages in presenilin 1 E280A familial early-onset Alzheimer's disease: a retrospective cohort study Lancet Neurol 10 2011 213 220
31. R.A. Sperling, B.C. Dickerson, M. Pihlajamaki, P. Vannini, P.S. LaViolette, and O.V. Vitolo et al. Functional alterations in memory networks in early Alzheimer's disease Neuromol Med 12 2010 27 43
32. E.C. Petrie, D.J. Cross, D. Galasko, G.D. Schellenberg, M.A. Raskind, and E.R. Peskind et al. Preclinical evidence of Alzheimer changes: convergent cerebrospinal fluid biomarker and fluorodeoxyglucose positron emission tomography findings Arch Neurol 66 2009 632 637
33. E.M. Reiman, R.J. Caselli, L.S. Yun, K. Chen, D. Bandy, and S. Minoshima et al. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E New Engl J Med 334 1996 752 758
34. A.S. Fleisher, K. Chen, Y.T. Quiroz, L.J. Jakimovich, M.G. Gomez, and C.M. Langois et al. Florbetapir PET analysis of amyloid-beta deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional study Lancet Neurol 11 2012 1057 1065
35. E.M. Reiman, Y.T. Quiroz, A.S. Fleisher, K. Chen, C. Velez-Pardo, and M. Jimenez-Del-Rio et al. Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study Lancet Neurol 11 2012 1048 1056
36. E.M. Reiman, J.B. Langbaum, A.S. Fleisher, R.J. Caselli, K. Chen, and N. Ayutyanont et al. Alzheimer's Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatments J Alzheimers Dis 26 suppl 3) 2011 321 329
37. American Psychiatric Association Diagnostic and statistical manual of mental disorders 4th ed. 2000 American Psychiatric Association Washington, DC
38. S.W. Provencher Automatic quantitation of localized in vivo 1H spectra with LCModel NMR Biomed 14 2001 260 264
39. A. Bakkour, J.C. Morris, D.A. Wolk, and B.C. Dickerson The effects of aging and Alzheimer's disease on cerebral cortical anatomy: specificity and differential relationships with cognition Neuroimage 76 2013 332 344
40. K. Kantarci, R.C. Petersen, S.A. Przybelski, S.D. Weigand, M.M. Shiung, and J.L. Whitwell et al. Hippocampal volumes, proton magnetic resonance spectroscopy metabolites, and cerebrovascular disease in mild cognitive impairment subtypes Arch Neurol 65 2008 1621 1628
41. A.K. Godbolt, A.D. Waldman, D.G. MacManus, J.M. Schott, C. Frost, and L. Cipolotti et al. MRS shows abnormalities before symptoms in familial Alzheimer disease Neurology 66 2006 718 722
42. M.J. Rowan, I. Klyubin, Q. Wang, and R. Anwyl Synaptic plasticity disruption by amyloid beta protein: modulation by potential Alzheimer's disease modifying therapies Biochem Soc Trans 33 2005 563 567
43. K. Kantarci, and C.R. Jack Jr. Neuroimaging in Alzheimer disease: an evidence-based review Neuroimag Clin North Am 13 2003 197 209
44. P.H. Reddy Mitochondrial dysfunction in aging and Alzheimer's disease: strategies to protect neurons Antioxid Redox Signal 9 2007 1647 1658
45. L.M. Nagae-Poetscher, D. Bonekamp, P.B. Barker, L.J. Brant, W.E. Kaufmann, and A. Horska Asymmetry and gender effect in functionally lateralized cortical regions: a proton MRS imaging study J Magn Res Imaging 19 2004 27 33
46. A.E. Cavanna, and M.R. Trimble The precuneus: a review of its functional anatomy and behavioural correlates Brain 129 2006 564 583
47. S. van Duijn, R.J. Nabuurs, S.G. van Duinen, R. Natte, M.A. van Buchem, and A. Alia Longitudinal monitoring of sex-related in vivo metabolic changes in the brain of Alzheimer's disease transgenic mouse using magnetic resonance spectroscopy J Alzheimers Disease 34 2013 1051 1059
48. M. Haris, K. Nath, K. Cai, A. Singh, R. Crescenzi, and F. Kogan et al. Imaging of glutamate neurotransmitter alterations in Alzheimer's disease [published online ahead of print October 9] NMR Biomed 2012
49. S. Mitew, M.T. Kirkcaldie, T.C. Dickson, and J.C. Vickers Altered synapses and gliotransmission in Alzheimer's disease and AD model mice Neurobiol Aging 34 2013 2341 2351
50. M.C. Gueli, and G. Taibi Alzheimer's disease: amino acid levels and brain metabolic status Neurol Sci 34 2013 1575 1579
51. R. Migliaccio, F. Agosta, K.L. Possin, G.D. Rabinovici, B.L. Miller, and M.L. Gorno-Tempini White matter atrophy in Alzheimer's disease variants Alzheimers Dement 8 2012 S78 S87.e1-e2
52. M. Bozzali, A. Padovani, C. Caltagirone, and B. Borroni Regional grey matter loss and brain disconnection across Alzheimer disease evolution Curr Med Chem 18 2011 2452 2458
53. M. Bozzali, G.J. Parker, L. Serra, K. Embleton, T. Gili, and R. Perri et al. Anatomical connectivity mapping: a new tool to assess brain disconnection in Alzheimer's disease Neuroimage 54 2011 2045 2051
54. J.F. Jansen, W.H. Backes, K. Nicolay, and M.E. Kooi 1H MR spectroscopy of the brain: absolute quantification of metabolites Radiology 240 2006 318 332